NCT06239207Phase 2Completed
Efficacy and Safety of Exosomes Versus Platelet Rich Plasma in Patients of Androgenetic Alopecia
In the register
This trial is not attached to a programme in the register yet. Unattached trials are kept on purpose: they are where new programmes turn up first.
What the registry records
- Status
- Completed
- Declared phase
- Phase 2
- Sponsor
- Services Hospital, Lahore
- Participants (registry)
- 30
- Start
- September 2023
- Primary completion
- July 2024
- Study completion
- July 2024
- Last registry update
- October 2024
- Countries
- Pakistan
Conditions studied: Androgenetic Alopecia
Interventions: Exosomes GFC CELL EXO SCALP KIT (Leuco Exo 97%), Platelet Rich Plasma
Listing a trial is not a recommendation to join one. Eligibility, risks and costs vary enormously — discuss any trial with your own doctor first. A registration proves a sponsor declared a study, not that it is progressing or will succeed. We're not doctors.